• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受高剂量抗叶酸疗法患者血清中的蛋白质-甲氨蝶呤-IgG复合物

Protein-methotrexate-IgG complexes in the serum of patients receiving high-dose antifolate therapy.

作者信息

da Costa M, Isacoff W, Rothenberg S P, Iqbal M P

出版信息

Cancer. 1980 Aug 1;46(3):471-4. doi: 10.1002/1097-0142(19800801)46:3<471::aid-cncr2820460309>3.0.co;2-o.

DOI:10.1002/1097-0142(19800801)46:3<471::aid-cncr2820460309>3.0.co;2-o
PMID:6930984
Abstract

Three patients who were treated repetitive courses of high-dose methotrexate and leucovorin rescue experienced hypersensitivity symptoms infusion of the drug. Serum from all three patients contained one complex of methotrexate bound to a protein similar in size to albumin and a second complex of the protein-bound methotrexate coupled to IgG. This immune complex was not found in 4 patients similarly treated who did not experience hypersensitivity symptoms.

摘要

三名接受大剂量甲氨蝶呤和亚叶酸解救重复疗程治疗的患者在输注该药物时出现了过敏症状。所有三名患者的血清中都含有一种与白蛋白大小相似的蛋白质结合的甲氨蝶呤复合物,以及第二种与IgG偶联的蛋白质结合甲氨蝶呤复合物。在另外四名接受类似治疗但未出现过敏症状的患者中未发现这种免疫复合物。

相似文献

1
Protein-methotrexate-IgG complexes in the serum of patients receiving high-dose antifolate therapy.接受高剂量抗叶酸疗法患者血清中的蛋白质-甲氨蝶呤-IgG复合物
Cancer. 1980 Aug 1;46(3):471-4. doi: 10.1002/1097-0142(19800801)46:3<471::aid-cncr2820460309>3.0.co;2-o.
2
Treatment of primary osteosarcoma with intra-arterial and intravenous high-dose methotrexate.采用动脉内和静脉内高剂量甲氨蝶呤治疗原发性骨肉瘤。
J Clin Oncol. 1983 Jul;1(7):428-31. doi: 10.1200/JCO.1983.1.7.428.
3
Preoperative administration of high-dose methotrexate for osteosarcoma.骨肉瘤高剂量甲氨蝶呤的术前给药
Can J Surg. 1984 May;27(3):305-7, 309.
4
[The effect of methotrexate pharmacokinetics and of leucovorin rescue on the prognosis of osteosarcoma].[甲氨蝶呤药代动力学及亚叶酸钙解救对骨肉瘤预后的影响]
Klin Padiatr. 1990 Sep-Oct;202(5):340-6. doi: 10.1055/s-2007-1025542.
5
[Immune complex formation and complement changes in osteosarcoma patients treated with high-dose methotrexate].[大剂量甲氨蝶呤治疗骨肉瘤患者的免疫复合物形成及补体变化]
Klin Padiatr. 1987 Jan-Feb;199(1):22-6. doi: 10.1055/s-2008-1026753.
6
Vincristine in the etiology of toxicity of high-dose methotrexate therapy.长春新碱在大剂量甲氨蝶呤治疗毒性病因学中的作用
Cancer. 1980 Dec 15;46(12):2571-2. doi: 10.1002/1097-0142(19801215)46:12<2571::aid-cncr2820461206>3.0.co;2-w.
7
Mega doses of methotrexate in the treatment of osteosarcoma.大剂量甲氨蝶呤治疗骨肉瘤
J Pak Med Assoc. 1990 Oct;40(10):248-51.
8
High-performance liquid chromatographic and enzyme-inhibition assays of methotrexate concentrations in serum from patients receiving high-dose therapy: tight binding of some methotrexate to a protein that could be dihydrofolate reductase.接受高剂量治疗患者血清中甲氨蝶呤浓度的高效液相色谱法和酶抑制测定:部分甲氨蝶呤与一种可能是二氢叶酸还原酶的蛋白质紧密结合。
Cancer Treat Rep. 1985 Jul-Aug;69(7-8):825-32.
9
High-dose methotrexate with a safe rescue program.大剂量甲氨蝶呤联合安全解救方案。
Oncology. 1981;38(5):262-4. doi: 10.1159/000225566.
10
[High-dose methotrexate with blood monitoring in patients with osteosarcoma].骨肉瘤患者大剂量甲氨蝶呤治疗并进行血液监测
Medicina (B Aires). 1978 May-Jun;38(3):221-5.

引用本文的文献

1
Sensitization to low dose 5-fluorouracil. Subsequent enhancement of its systemic antitumor effect in the rat.对低剂量5-氟尿嘧啶的致敏作用。随后其在大鼠体内全身抗肿瘤作用的增强。
J Clin Invest. 1982 Sep;70(3):558-67. doi: 10.1172/jci110648.
2
Antigens in immune complexes from patients with breast cancer. Identification of autoantigens in immune complexes isolated from breast cancer effusions.乳腺癌患者免疫复合物中的抗原。从乳腺癌积液中分离出的免疫复合物中自身抗原的鉴定。
Cancer Immunol Immunother. 1982;13(3):153-7. doi: 10.1007/BF00205380.
3
Hypersensitivity reactions from antineoplastic agents.
抗肿瘤药物引起的超敏反应。
Cancer Metastasis Rev. 1987;6(3):413-32. doi: 10.1007/BF00144273.
4
Study of histamine release induced by acute administration of antitumor agents in dogs.犬急性给予抗肿瘤药物诱导组胺释放的研究。
Cancer Chemother Pharmacol. 1988;21(3):246-50. doi: 10.1007/BF00262779.
5
Survival after unexpected high serum methotrexate concentrations in a patient with osteogenic sarcoma.
Drug Saf. 1990 Nov-Dec;5(6):447-54. doi: 10.2165/00002018-199005060-00005.
6
Hypersensitivity reactions to trimetrexate.
Invest New Drugs. 1990 May;8(2):211-4. doi: 10.1007/BF00177263.